Literature DB >> 20568114

Role for transcription factor TFII-I in the suppression of SSeCKS/Gravin/Akap12 transcription by Src.

Yahao Bu1, Lingqiu Gao, Irwin H Gelman.   

Abstract

The SSeCKS/Gravin/AKAP12 gene, encoding a kinase scaffolding protein with metastasis-suppressing activity, is transcriptionally downregulated in Src-transformed cells through the recruitment of HDAC1 to a Src-responsive proximal promoter site charged with Sp1, Sp3 and USF1. However, the ectopic expression of these proteins formed a suppressive complex in Src-transformed but not in parental NIH3T3 cells, suggesting the involvement of additional repressor factors. Transcription factor II-I (TFII-I) [general transcription factor 2i (Gtf2i)] was identified by mass spectrometry as being associated with the SSeCKS promoter complex in NIH3T3/Src cells, and moreover, the Src-induced tyrosine phosphorylation of TFII-I significantly increased its binding to the SSeCKS proximal promoter. siRNA-mediated knockdown of TFII-I or the expression of TFII-I(Y248/249F) caused the derepression of SSeCKS in NIH3T3/Src cells. Taken with previous data showing that the tyrosine phosphorylation of TFII-I facilitates its nuclear translocation, these data suggest that Src-family kinase-mediated phosphorylation converts a portion of TFII-I into a transcriptional repressor.
Copyright © 2010 UICC.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20568114      PMCID: PMC2997892          DOI: 10.1002/ijc.25524

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  38 in total

1.  Synergistic cooperation between the AP-1 and LEF-1 transcription factors in activation of the matrilysin promoter by the src oncogene: implications in cellular invasion.

Authors:  Christine Rivat; Nathalie Le Floch; Michèle Sabbah; Isabelle Teyrol; Gérard Redeuilh; Erik Bruyneel; Marc Mareel; Lynn M Matrisian; Howard C Crawford; Christian Gespach; Samir Attoub
Journal:  FASEB J       Date:  2003-07-18       Impact factor: 5.191

Review 2.  Newest findings on the oldest oncogene; how activated src does it.

Authors:  Margaret C Frame
Journal:  J Cell Sci       Date:  2004-03-01       Impact factor: 5.285

Review 3.  Regulation of gene expression in oncogenically transformed cells.

Authors:  M Dehbi; P A Bédard
Journal:  Biochem Cell Biol       Date:  1992 Oct-Nov       Impact factor: 3.626

Review 4.  Cell transformation by the viral src oncogene.

Authors:  R Jove; H Hanafusa
Journal:  Annu Rev Cell Biol       Date:  1987

5.  Transcriptional downregulation of the retina-specific QR1 gene by pp60v-src and identification of a novel v-src-responsive unit.

Authors:  A Pierani; C Pouponnot; G Calothy
Journal:  Mol Cell Biol       Date:  1993-06       Impact factor: 4.272

6.  Physical and functional interactions of histone deacetylase 3 with TFII-I family proteins and PIASxbeta.

Authors:  María Isabel Tussié-Luna; Dashzeveg Bayarsaihan; Edward Seto; Frank H Ruddle; Ananda L Roy
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-18       Impact factor: 11.205

7.  Trichostatin A, a histone deacetylase inhibitor, activates the IGFBP-3 promoter by upregulating Sp1 activity in hepatoma cells: alteration of the Sp1/Sp3/HDAC1 multiprotein complex.

Authors:  Hong Seok Choi; Je Ho Lee; Jong Gu Park; Young Ik Lee
Journal:  Biochem Biophys Res Commun       Date:  2002-08-30       Impact factor: 3.575

8.  A candidate X-linked mental retardation gene is a component of a new family of histone deacetylase-containing complexes.

Authors:  Mohamed-Ali Hakimi; Yuanshu Dong; William S Lane; David W Speicher; Ramin Shiekhattar
Journal:  J Biol Chem       Date:  2002-12-18       Impact factor: 5.157

9.  Requirement of a specific Sp1 site for histone deacetylase-mediated repression of transforming growth factor beta Type II receptor expression in human pancreatic cancer cells.

Authors:  Shujie Zhao; Kolaparthi Venkatasubbarao; Senlin Li; James W Freeman
Journal:  Cancer Res       Date:  2003-05-15       Impact factor: 12.701

10.  Mechanism of Bruton's tyrosine kinase-mediated recruitment and regulation of TFII-I.

Authors:  Catarina Sacristán; María Isabel Tussié-Luna; Sheila M Logan; Ananda L Roy
Journal:  J Biol Chem       Date:  2003-11-17       Impact factor: 5.157

View more
  10 in total

Review 1.  Suppression of tumor and metastasis progression through the scaffolding functions of SSeCKS/Gravin/AKAP12.

Authors:  Irwin H Gelman
Journal:  Cancer Metastasis Rev       Date:  2012-12       Impact factor: 9.264

2.  Dual Src Kinase/Pretubulin Inhibitor KX-01, Sensitizes ERα-negative Breast Cancers to Tamoxifen through ERα Reexpression.

Authors:  Muralidharan Anbalagan; Mei Sheng; Brian Fleischer; Yifang Zhang; Yuanjun Gao; Van Hoang; Margarite Matossian; Hope E Burks; Matthew E Burow; Bridgette M Collins-Burow; David Hangauer; Brian G Rowan
Journal:  Mol Cancer Res       Date:  2017-07-27       Impact factor: 5.852

Review 3.  Biochemistry and biology of the inducible multifunctional transcription factor TFII-I: 10 years later.

Authors:  Ananda L Roy
Journal:  Gene       Date:  2011-10-21       Impact factor: 3.688

4.  Mutant GTF2I induces cell transformation and metabolic alterations in thymic epithelial cells.

Authors:  In-Kyu Kim; Guanhua Rao; Xiaoliang Zhao; Ruzong Fan; Maria Laura Avantaggiati; Yisong Wang; Yu-Wen Zhang; Giuseppe Giaccone
Journal:  Cell Death Differ       Date:  2020-02-07       Impact factor: 15.828

5.  Emerging Roles for SSeCKS/Gravin/AKAP12 in the Control of Cell Proliferation, Cancer Malignancy, and Barriergenesis.

Authors:  Irwin H Gelman
Journal:  Genes Cancer       Date:  2010-11

Review 6.  AKAP signaling complexes: pointing towards the next generation of therapeutic targets?

Authors:  Jessica L Esseltine; John D Scott
Journal:  Trends Pharmacol Sci       Date:  2013-11-12       Impact factor: 14.819

7.  Sp1 expression regulates lung tumor progression.

Authors:  T-I Hsu; M-C Wang; S-Y Chen; Y-M Yeh; W-C Su; W-C Chang; J-J Hung
Journal:  Oncogene       Date:  2011-12-12       Impact factor: 9.867

8.  A genome-wide RNAi screen identifies FOXO4 as a metastasis-suppressor through counteracting PI3K/AKT signal pathway in prostate cancer.

Authors:  Bing Su; Lingqiu Gao; Catherine Baranowski; Bryan Gillard; Jianmin Wang; Ryan Ransom; Hyun-Kyung Ko; Irwin H Gelman
Journal:  PLoS One       Date:  2014-07-01       Impact factor: 3.240

Review 9.  The molecular effect of metastasis suppressors on Src signaling and tumorigenesis: new therapeutic targets.

Authors:  Wensheng Liu; Zaklina Kovacevic; Zhihai Peng; Runsen Jin; Puxiongzhi Wang; Fei Yue; Minhua Zheng; Michael L-H Huang; Patric J Jansson; Vera Richardson; Danuta S Kalinowski; Darius J R Lane; Angelica M Merlot; Sumit Sahni; Des R Richardson
Journal:  Oncotarget       Date:  2015-11-03

10.  Ret finger protein-like 3 promotes tumor cell growth by activating telomerase reverse transcriptase expression in human lung cancer cells.

Authors:  Wangbing Chen; Jianjun Lu; Yu Qin; Jingshu Wang; Yun Tian; Dingbo Shi; Shusen Wang; Yao Xiao; Meng Dai; Lu Liu; Guo Wei; Taihua Wu; Bilian Jin; Xiangsheng Xiao; Tie-Bang Kang; Wenlin Huang; Wuguo Deng
Journal:  Oncotarget       Date:  2014-12-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.